Cargando…
Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency
BACKGROUND: Exocrine pancreatic insufficiency (EPI) is characterized by the loss of active pancreatic enzymes and a resulting severely reduced food digestion. EPI therapy requires orally applied pancreatic enzyme replacement. The gut microbiome is a known mediator of intestinal diseases and may infl...
Autores principales: | Ritz, Sabrina, Hahn, Daniela, Wami, Haleluya T., Tegelkamp, Karin, Dobrindt, Ulrich, Schnekenburger, Juergen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713139/ https://www.ncbi.nlm.nih.gov/pubmed/33272255 http://dx.doi.org/10.1186/s12934-020-01482-2 |
Ejemplares similares
-
Gut microbiome and plasma metabolome changes in rats after oral gavage of nanoparticles: sensitive indicators of possible adverse health effects
por: Landsiedel, Robert, et al.
Publicado: (2022) -
Comparative Genomics of Emerging Lineages and Mobile Resistomes of Contemporary Broiler Strains of Salmonella Infantis and E. coli
por: Szmolka, Ama, et al.
Publicado: (2021) -
Responses of Ileal and Fecal Microbiota to Withdrawal of Pancreatic Enzyme Replacement Therapy in a Porcine Model of Exocrine Pancreatic Insufficiency
por: Hankel, Julia, et al.
Publicado: (2022) -
Long term follow-up of a simplified and less burdened pancreatic duct ligation model of exocrine pancreatic insufficiency in Goettingen Minipigs
por: Luu, Andreas Minh, et al.
Publicado: (2020) -
Survey of Pancreatic Enzyme Replacement Therapy Dosing Experiences in Adults with Exocrine Pancreatic Insufficiency
por: Lewis, Dana M., et al.
Publicado: (2023)